ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 324 filers reported holding ARRAY BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 1.86 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $25,666,000 | -5.9% | 553,980 | -50.5% | 0.68% | -1.4% |
| Q1 2019 | $27,261,000 | +44.0% | 1,118,187 | -15.8% | 0.70% | +29.7% |
| Q4 2018 | $18,930,000 | -20.3% | 1,328,402 | -15.0% | 0.54% | +13.1% |
| Q3 2018 | $23,751,000 | -13.0% | 1,562,566 | -4.0% | 0.47% | -16.0% |
| Q2 2018 | $27,313,000 | +47.6% | 1,627,696 | +43.6% | 0.56% | +50.4% |
| Q1 2018 | $18,503,000 | +389.5% | 1,133,732 | +283.9% | 0.38% | +420.8% |
| Q4 2017 | $3,780,000 | +26.0% | 295,320 | +21.1% | 0.07% | +41.2% |
| Q3 2017 | $3,000,000 | +68.0% | 243,934 | +14.3% | 0.05% | +70.0% |
| Q2 2017 | $1,786,000 | -48.1% | 213,425 | -44.5% | 0.03% | -37.5% |
| Q1 2017 | $3,439,000 | -26.3% | 384,699 | -27.5% | 0.05% | -21.3% |
| Q4 2016 | $4,666,000 | -41.9% | 530,806 | -55.4% | 0.06% | -29.9% |
| Q3 2016 | $8,033,000 | +336.3% | 1,190,070 | +130.1% | 0.09% | +383.3% |
| Q2 2016 | $1,841,000 | -27.1% | 517,196 | -39.6% | 0.02% | -21.7% |
| Q1 2016 | $2,525,000 | -14.2% | 855,830 | +22.8% | 0.02% | -4.2% |
| Q4 2015 | $2,942,000 | -29.3% | 697,122 | -23.6% | 0.02% | -29.4% |
| Q3 2015 | $4,163,000 | -38.0% | 912,908 | -2.0% | 0.03% | -27.7% |
| Q2 2015 | $6,715,000 | -4.2% | 931,389 | -2.0% | 0.05% | -2.1% |
| Q1 2015 | $7,006,000 | +14.6% | 950,645 | -26.4% | 0.05% | +11.6% |
| Q4 2014 | $6,113,000 | +126.1% | 1,292,428 | +70.6% | 0.04% | +126.3% |
| Q3 2014 | $2,704,000 | -3.6% | 757,378 | +23.1% | 0.02% | 0.0% |
| Q2 2014 | $2,805,000 | +23.4% | 615,115 | +27.2% | 0.02% | +26.7% |
| Q1 2014 | $2,274,000 | +82.7% | 483,751 | +94.7% | 0.02% | +66.7% |
| Q4 2013 | $1,245,000 | -53.2% | 248,405 | -41.9% | 0.01% | -52.6% |
| Q3 2013 | $2,660,000 | – | 427,651 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|